Aethlon Medical (NASDAQ:AEMD) Now Covered by initiated coverage on shares of Aethlon Medical (NASDAQ:AEMDFree Report) in a report released on Saturday morning. The brokerage issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright cut their target price on shares of Aethlon Medical from $23.00 to $10.00 and set a buy rating on the stock in a report on Monday, March 4th.

View Our Latest Stock Analysis on Aethlon Medical

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.64 on Friday. Aethlon Medical has a 52-week low of $0.37 and a 52-week high of $5.00. The stock has a market cap of $1.68 million, a PE ratio of -0.13 and a beta of 1.60. The firm’s 50 day moving average price is $0.95 and its two-hundred day moving average price is $1.52.

About Aethlon Medical

(Get Free Report)

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.

Featured Stories

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with's FREE daily email newsletter.